iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA – Get Free Report) dropped 0.5% on Wednesday . The company traded as low as $24.19 and last traded at $24.28. Approximately 11,420 shares changed hands during trading, a decline of 67% from the average daily volume of 34,355 shares. The stock had previously closed at $24.40.
iShares Genomics Immunology and Healthcare ETF Price Performance
The stock has a market cap of $139.99 million, a P/E ratio of 2.29 and a beta of 1.14. The company has a 50 day simple moving average of $24.26 and a 200-day simple moving average of $23.85.
iShares Genomics Immunology and Healthcare ETF Company Profile
The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.
Further Reading
- Five stocks we like better than iShares Genomics Immunology and Healthcare ETF
- Insider Buying Explained: What Investors Need to Know
- Does GTA VI Make Take-Two Interactive Stock an Irresistible Buy?
- How to Find Undervalued Stocks
- Why HPE’s Dip Is a Prime Opportunity for Blue-Chip AI Investors
- Learn Technical Analysis Skills to Master the Stock Market
- Why Analysts See Big Upside for Occidental Petroleum Despite Lows
Receive News & Ratings for iShares Genomics Immunology and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Genomics Immunology and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.
